Risk factor
Moderate default risk
Profitability factor
Greatly overvalued vs peers
About
AVE Science&Technology CO.,LTD operates comprehensively in the medical technology sector, engaging in the full spectrum of activities from initial research and development to manufacturing, sales, and post-sale support. Its diverse portfolio includes medical devices, biological reagents, remote medical diagnostic networks, specialized computer software, automated control systems, and various medical auxiliary equipment. The company's product offerings prominently feature advanced diagnostic instruments, such as analyzers for urine formed elements (along with their associated reagents), automated urine analysis systems, multi-functional microscopy devices, semi-automatic biochemical analyzers, and feces analyzers. Complementing these devices, AVE Science&Technology also supplies essential consumables, including reagent kits, quality control solutions for analyzers, test strips, and cleaning agents. Serving a global clientele, the company's reach extends across Europe, the United States, Asia, and Africa. Established in 2000, AVE Science&Technology CO.,LTD is headquartered in Changsha, China. The organization transitioned to its present name in September 2012, having previously been known as Changsha High - tech Industrial Development Zone Aiwei Technology Industrial Co., Ltd.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued